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associated secretory phenotype (SASP). In otherwise healthy individuals, osteocytes
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Age‐related bone loss is attributed to the accumulation of senescent cells and their

play a key role in maintaining bone mass through their primary function of
responding to skeletal loading. Given that osteocytes' response to loading is known
to steadily decline with age, we hypothesized that the increasing presence of senescent cells and their SASP inhibit osteocytes' response to loading. To test this
hypothesis, we developed two in vitro models of senescent osteocytes and osteoblasts derived from MLO‐Y4 and MC3T3 cell lines, respectively. The senescent
phenotype was unique to each cell type based on distinct changes in cell cycle
inhibitors and SASP profile. The SASP profile of senescent osteocytes was in part
dependent on nuclear factor‐κB signaling and presents a new potential mechanism
to target the SASP in bone. Nonsenescent MLO‐Y4 cells cultured with the SASP of
each senescent cell type failed to exhibit changes in gene expression as well as ERK
phosphorylation and prostaglandin E2 release. The SASP of senescent osteocytes
had the largest effect and neutralizing interleukin‐6 (IL‐6) as part of the SASP
restored osteocytes' response to loading. The loss in mechanotransduction due to
IL‐6 was attributed to a decrease in P2X7 expression and overall sensitivity to
purinergic signaling. Altogether, these findings demonstrate that the SASP of
senescent cells have a negative effect on the mechanotransduction of osteocytes
and that IL‐6 is a key SASP component that contributes to the loss in
mechanotransduction.
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| INTRODUCTION

(Holguin et al., 2014; Rubin et al., 1992; Srinivasan et al., 2003;
Turner et al., 1995), limiting the anabolic effect of physical loading

Osteocytes are ideally placed throughout the cortex of bone to sense

and exercise in adults (Bielemann et al., 2013; Forwood & Burr, 1993;

mechanical loading and initiate bone formation to maintain bone

Gomez‐Cabello et al., 2012; Kohrt, 2001; Marques et al., 2012;

mass and overall strength (Bonewald & Johnson, 2008; Uda et al.,

Nikander et al., 2010; Rubin et al., 1992). The lack of response to

2017). However, the anabolic response to loading declines with age

loading at the tissue level is in part attributed to a decline in

J Cell Physiol. 2022;1–9.
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osteocyte function and shift in mechanotransduction (Galea et al.,

ET AL.

phosphorylated ERK1/2 (#9101) were purchased from Cell Signaling

2017; Hemmatian et al., 2017; Jilka & O'Brien, 2016; Srinivasan et al.,

Technologies. The antibody for P2X7 (#APR‐008) was purchased from

2012). Age‐related changes in osteocytes' response to loading in-

Alomone Labs. Neutralizing antibodies against IL‐6 (#AF‐406) and IL‐1α

clude a decrease in intracellular calcium signaling (Morrell et al., 2020)

(#AF‐400) were purchased from R&D Systems, Inc. Unless noted, all

alongside an incapacity to regulate sclerostin and wnt ligands

other chemicals were purchased from Invitrogen.

(Gardinier et al., 2018; Holguin et al., 2016). In vitro studies involving
primary osteocytes have also found aging to shift the biological response to loading, specifically related to nitric oxide (NO) and
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Cell culture

cyclooxygenase‐2 production (Chalil et al., 2015). The underlying
mechanisms by which osteocytes' response to loading is lost with age

Osteocyte‐like MLO‐Y4 cells were cultured in Petri dishes coated

remains unclear and presents a limitation in developing new ther-

with rat type‐1 collagen (BD Biosciences). Growth media consisted of

apeutic approaches toward preventing age‐related bone loss.

α‐minimum essential medium (α‐MEM) supplemented with 2.5% FBS,

One of the hallmarks of the aging process is the accumulation of

2.5% CS, and 1% penicillin–streptomycin (P/S). Osteoblast‐like

senescent cells and their inflammatory phenotype (Baker et al., 2011; Farr

MC3T3‐E1 cells were cultured in α‐MEM containing 10% FBS and

et al., 2017; Roos et al., 2016). Senescent cells are characterized by ex-

1% P/S. Cells were maintained in a humidified incubator at 37°C and

tensive genomic changes that lead to proliferative arrest and the release

5% CO2 and were not allowed to exceed 70%–80% confluency to

of inflammatory cytokines as a part of the senescence‐associated se-

maintain the phenotype of each cell type.

cretory phenotype (SASP) (Coppe et al., 2010; Freund et al., 2010;
Hernandez‐Segura et al., 2018). The inflammatory cytokines released by
senescent cells contribute to a state of low‐grade chronic inflammation

2.3 |

Generation of SASP conditioned media

that extends beyond their local environment and impact the function of
neighboring tissues (Xu et al., 2018). Eliminating senescent cells or tar-

Senescence was induced by exposing each cell type to a single dose

geting their SASP in aged mice has been shown to prevent bone loss by

(10 Gy) of cesium irradiation in a Cs‐137 irradiator. Radiated and non-

increasing bone formation and reducing bone resorption (Farr et al.,

irradiated controls were then cultured for an additional 10 days before

2017). Although the shift in bone remodeling is attributed to gains in

collecting conditioned media over a period of 24 h. The conditioned

osteocyte function, the extent to which osteocyte mechanotransduction

media was centrifuged and filtered to remove cell debris. After collecting

is affected by senescent cells is entirely unclear.

the conditioned media, cells were fixed with 4% paraformaldehyde and

Senescent cells within the bone microenvironment produce several

stained for senescence‐associated β‐galactosidase (SA‐βGal) activity at a

inflammatory cytokines that include interleukin‐1α (IL‐1α), interleukin‐6

pH of 6.0 using freshly prepared 1 mg/ml X‐gal (5‐bromo‐4‐chloro‐3‐

(IL‐6), interleukin‐8 (IL‐8), and tumor necrosis factor‐α (TNF‐α) (Farr et al.,

indolyl β‐D‐galactoside), 5 mM potassium ferricyanide, 5 mM potassium

2016, 2017). Independent of the SASP, cytokines can have differing ef-

ferrocyanide, and 2 mM MgCl2 in phosphate‐buffered saline (PBS). Ad-

fects on osteocytes' mechanotransduction (Bakker et al., 2009, 2014).

ditional samples of senescent cells were used to collect messenger RNA

Therefore, the purpose of this study was to examine how osteocytes'

(mRNA) samples to examine changes in gene expression.

response to mechanical stimuli is affected by the unique cytokine profile
of senescent osteocytes' and osteoblasts' SASP. Based on our results, the
SASP of senescent osteocytes suppresses the mechanotransduction of

2.4 |

In vitro fluid flow

normal osteocytes to a greater degree than the SASP produced by senescent osteoblasts. Furthermore, the production of IL‐6 by senescent

Nonsenescent MLO‐Y4 cells were seeded on rat type‐1 collagen‐coated

osteocytes was largely regulated by aberrant nuclear factor‐κB (NF‐κB)

glass slides at a density of 1 × 103 cells/cm2. After 24 h, the media were

signaling and was responsible for suppressing the mechanotransduction

replaced with conditioned media from senescent or nonsenescent cells

of normal osteocytes. Altogether, these findings demonstrate that se-

and then cultured for another 2 days. Cells were then washed with PBS

nescent osteocytes accumulating in cortical bone have a negative effect

and exposed to oscillatory fluid flow (OFF) using a parallel plate chamber

on the mechanotransduction of neighboring osteocytes through the

as described previously (Jacobs et al., 1998). Briefly, laminar fluid flow in

paracrine function of IL‐6 as part of the SASP.

the chamber was controlled by a crank‐rocker mechanism, which generated a sinusoidal flow at 1 Hz with a peak shear stress of 20 dynes/cm2.
Flow media consisted of α‐MEM with 1% FBS and 1% P/S.

2
2.1

| M E TH O D S
| Reagents and antibodies

2.5 |

Gene expression

Fetal bovine serum (FBS) and calf serum (CS) were obtained from Sigma‐

Trizol extracted mRNA was purified (RNeasy® Mini Kit; Qiagen) and

Aldrich along with culture media, trypsin EDTA, antibiotics, and adenosine

then used to generate complementary DNA (cDNA) (Taqman cDNA

5′‐triphosphate (ATP). Antibodies against total ERK1/2 (#9107) and

Synthesis Kit; Applied Biosystems). An Applied BioSystems 7500

GARDINIER
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RealTime PCR machine was used for real‐time quantitative PCR (qRT‐

dihydrochloride, and 2.5 M H3PO4). Concentrations for ATP, NO, and

PCR) along with the following Taqman primers: Tbp (Mm01277042),

PGE2 were normalized by the respective cell lysate protein con-

Tnfsf11 (Rankl, Mm00441906), Tnfrsf11b (Opg, Mm00435454), Ptgs2

centration, which was measured via Pierce™ BCA Protein Assay Kit

(Mm00478374), Dkk1 (Mm00438422), and Wnt10b (Mm00442104).

(Thermo Scientific Scientific).

All samples were normalized to their respective expression of Tbp
using the 2−ΔΔCt method.

2.8 |
2.6

| Western blot analysis

Statistical analysis

All outcome measures are reported as the group mean ± standard
deviation. For each measurement variable, a one‐way analysis of

Cell lysates were prepared using radioimmunoprecipitation assay

variance alongside Tukey's post hoc testing to identify significant

buffer (140 mM NaCl, 10 mM Tris‐HCl, 1 mM EGTA, 0.1% sodium

differences between groups. A p value less than 0.05 was considered

deoxycholate, 0.1% sodium dodecyl sulfate, 1% NP‐40, pH 7.5)

significant.

containing 1 mM of phenylmethylsulfonylfluoride (PMSF) and Halt™
Protease and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific). Cell lysates were separated on polyacrylamide gels and trans-

3 |

RESULTS

ferred to polyvinylidene difluoride membranes. Membranes were
blocked with Intercept® Blocking Buffer (LI‐COR, Inc.) and then incubated overnight at 4°C with appropriate primary antibodies fol-

3.1 | Osteocytes and osteoblasts display distinct
senescent phenotypes and SASP

lowed by IRDye® 800CW secondary antibodies (1:10,000 dilution,
LI‐COR, Inc.) for 1 h at room temperature. Bands were visualized

Irradiation of MC3T3 and MLO‐Y4 cells induced a senescent

using the LiCor Odyssey CLx scanner and densitometry was de-

phenotype that was characterized 10 days later by an increase in

termined using the NIH ImageJ software.

SA‐βGal (Figure 1a). Cells positive for SA‐βGal were also noted as
being larger in size compared with nonsenescent controls. Irradiated MC3T3 cells exhibited significantly increased gene ex-

2.7

| Release of secondary messengers

pression of p16 ink4a and decreased expression of p53, while p21
expression was not significantly changed compared with non-

ATP and prostaglandin E2 (PGE2) concentrations were measured

irradiated controls (Figure 1b). Irradiated MLO‐Y4 cells exhibited

using the luciferin–luciferase reaction (ATP Bioluminescence Assay

a significant increase in p16ink4a and p21 expression compared

Kit HS II; Roche) and the Prostaglandin E2 ELISA Kit (#514010;

with nonirradiated controls. Both cell lines expressed elevated

Cayman Chemical). NO concentration was measured using a Griess

levels of Il‐6, Il‐1α, Tnf‐α, and Cxcl15 (mouse analogous to IL‐8) 10

reagent

days after irradiation.

(1%

sulfanilamide,

0.1%

naphthylethylene‐diamine‐

F I G U R E 1 Irradiating MC3T3 and MLO‐Y4 cells produce distinct senescent phenotypes and SASP. (a) SA‐βGal was evident 10 days after
irradiation (10 Gy). The mRNA expression of (b) cell cyclic inhibitors p16ink4a, p21, and p53 as well as (c) inflammatory cytokines common to SASP
were measured and normalized against Tbp plotted as a fold change compared with NM. Significant differences with a p value <0.05 are denoted
by “a” for comparisons to respective nonsenescent control and “b” for comparisons to the respective senescent MLO‐Y4 control
(mean ± standard deviation, n = 4). IL‐6, interleukin‐6; SA‐βGal, senescence‐associated β‐galactosidase; SASP, senescence‐associated secretory
phenotype; TNF‐α, tumor necrosis factor‐α
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To examine the role of NF‐κB in regulating senescent cells'

compared with their respective static controls, while OFF sig-

production of cytokines, the senescent MLO‐Y4 cells were treated

nificantly increased Wnt10b expression only in osteocytes treated

for 2 days with JSH‐23 to inhibit the transcriptional activity of NF‐κB.

with OB‐SASP.

Treatment of senescent cells with JSH‐23 significantly increased p21
further and p53 when compared with the expression before treatment (Figure 1b). In addition, JSH‐23 treatment decreased the expression of Il‐6, Il‐1α, and Cxcl15 when compared with the expression

3.3 | Changes in osteocyte mechanotransduction
are mediated by IL‐6 more than IL‐1α

before treatment (Figure 1c). Overall, JSH‐23 had the greatest effect
on Il‐6 and Cxcl15.

For osteocytes cultured with NM, OFF significantly increased NO
and PGE2 release by 2.5‐ and 8‐fold, respectively, when compared with static controls (Figure 3a,b). The release of NO and

3.2 | OFF‐induced gene expression is impaired by
the SASP

PGE2 in response to OFF significantly decreased for osteocytes
cultured with Ocy‐SASP when compared with NM controls exposed to the same OFF. However, OFF still induced a small but

Nonsenescent osteocytes were cultured with conditioned media

significant increase in PGE2 release when compared with static

from senescent osteoblasts (OB‐SASP) and senescent osteocytes

Ocy‐SASP controls. For osteocytes cultured with OB‐SASP, the

(Ocy‐SASP) for 2 days before static or OFF conditions (Figure 2a).

release of NO and PGE2 was not statistically different compared

Under static conditions, both OB‐SASP and Ocy‐SASP significantly

to either OB‐SASP static controls or NM controls subjected to

increased Rankl expression by three‐ and sevenfold, respectively,

the same OFF. Both OB‐SASP and Ocy‐SASP inhibited ERK

while only Ocy‐SASP produced a significant decrease in Opg and

phosphorylation induced by OFF (Figure 3c).

Dkk1 by 53% and 80%, respectively, when compared with static

To understand which component of the Ocy‐SASP caused the

controls cultured with conditioned media from non‐senesenct cells

loss in mechanotransduction, IL‐6 and IL‐1α were neutralized by

(NM) (Figure 2b).

adding antibodies while culturing nonsenescent MLO‐Y4 cells

For osteocytes cultured with NM, OFF significantly decreased

with Ocy‐SASP. Neutralizing IL‐1α in the Ocy‐SASP failed to re-

Rankl and Dkk1 expression by 55% and 48%, respectively, and sig-

store osteocytes' response to OFF while neutralizing IL‐6 re-

nificantly increased Ptgs2 and Wnt10b expression by ~2‐ and ~2.5‐

stored osteocytes' release of NO and PGE2 in response to OFF

fold, respectively, when compared with static NM controls. For os-

alongside ERK phosphorylation (Figure 4). In particular, PGE2

teocytes cultured with OB‐SASP and Ocy‐SASP, OFF had no sig-

release in response to OFF was significantly greater in osteocytes

nificant effect on Rankl, Opg, Ptgs2, or Dkk1 expression when

treated with Ocy‐SASP and the IL‐6 antibody when compared

F I G U R E 2 Fluid flow‐induced gene expression of nonsenescent MLO‐Y4 cells is inhibited by the SASP of senescent osteocytes and
osteoblasts. (a) Our study design cultured nonsenescent MLO‐Y4 cells with conditioned media from senescent osteoblasts (OB‐SASP) or
osteocytes (Ocy‐SASP) for 2 days and then subjected them to 2 h of static or OFF conditions. (b) The mRNA expression of Rankl, Opg, Ptgs2,
Dkk1, and Wnt10b were measured relative to Tbp via qRT‐PCR analysis and then normalized to NM static controls. Significant differences with a
p value <0.05 are denoted by “a” for comparisons to respective static control and “b” for comparisons to the respective NM control
(mean ± standard deviation, n = 3). IL‐6, interleukin‐6; mRNA, messenger RNA; OFF, oscillatory fluid flow; qRT‐PCR, real‐time quantitative
PCR; SASP, senescence‐associated secretory phenotype
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F I G U R E 3 Fluid flow‐induced release of
secondary messengers and phosphorylation of
ERK of nonsenescent MLO‐Y4 cells are
inhibited by the SASP of senescent osteocytes
and osteoblasts. After 1 h of OFF, the
extracellular concentration of NO (a) and
PGE2 (b) were measured alongside
intracellular phosphorylation of ERK (c).
Significant differences with a p value <0.05
are denoted by “a” for comparisons to
respective static control and “b” for
comparisons to the respective NM control
(mean ± standard deviation, n = 4). NO, nitric
oxide; OB‐SASP, senescent osteoblasts; Ocy‐
SASP, osteocytes; OFF, oscillatory fluid flow;
PGE2, prostaglandin E2; SASP, senescence‐
associated secretory phenotype

with osteocytes treated with Ocy‐SASP alone (Figure 4b) or os-

4 |

D IS CU SS IO N

teocytes cultured with NM and the IL‐6 antibody (p < 0.001; see
Figure S1). Neutralizing IL‐6 in NM did not have a significant

Our findings demonstrate that the mechanotransduction of healthy

effect on either ERK phosphorylation (p < 0.56) or PGE2 release

osteocytes is negatively affected by the SASP of senescent osteo-

(p < 0.85) in response to OFF (Figure S1).

cytes and osteoblasts. The senescent phenotype of osteocytes and
osteoblasts were distinctly different between cell types based on
their unique changes in cell cycle inhibitors p21 and p53. The pro-

3.4 | The SASP decreases osteocytes' sensitivity to
purinergic signaling through P2X7

duction of IL‐6 by senescent osteocytes was in part dependent on
NF‐κB signaling and the fact that inhibiting NF‐κB was able to significantly reduce IL‐6 expression presents a new potential mechanism

Considering PGE2 and ERK phosphorylation under loading are

to targeting the SASP in bone. By comparison, senescent osteocytes

mediated via purinergic signaling (Li et al., 2005), we measured ATP

have a larger effect on the mechanotransduction of healthy osteo-

release and found fluid flow still induced a significant increase despite

cytes. A similar loss in PGE2 release and Wnt10b expression in re-

Ocy‐SASP (Figure 5a). However, directly treating osteocytes with

sponse to loading is reported to occur across different models of

ATP cultured with Ocy‐SASP failed to induce ERK phosphorylation

aging (Galea et al., 2017; Klein‐Nulend et al., 2002). Of the various

(Figure 5b). Neutralizing IL‐6 in Ocy‐SASP restored osteocytes

SASP components, IL‐6 had the largest contribution to the loss in

phosphorylation of ERK phosphorylation in response to ATP. We

mechanotransduction. Lastly, senescent osteocytes negatively im-

then measured the expression of P2X7 given its role in regulating

pacted the mechanotransduction of healthy osteocytes by way of

both ERK phosphorylation and PGE2 release under loading (Grol

decreasing the sensitivity to purinergic signaling, most notably

et al., 2009). The mRNA expression of P2X7 was not affected by the

through the loss of P2X7 expression. The absence of P2X7 in

SASP of senescent cells (Figure 5c). However, protein levels of P2X7

knockout mice is detrimental to the anabolic response to loading (Li

were significantly attenuated by 90% and then restored by 50%

et al., 2005). In aged mice, the extent to which P2X7 function remains

when neutralizing IL‐6 (Figure 5d).

unclear and warrants further examination based on our findings.
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F I G U R E 4 Neutralizing IL‐6 of the SASP
restores osteocytes' anabolic response to fluid
flow. Conditioned media from senescent
MLO‐Y4 cells (SASP) was supplemented with
neutralizing antibodies for IL‐1 (aIL‐1) or IL‐6
(aIL‐6). MLO‐Y4 cells were cultured for 2 days
with conditioned media from senescent
osteocytes (SASP) with and without the
neutralizing antibodies aIL‐1 or aIL‐6. After 1 h
of OFF, the extracellular concentration of NO
(a) and PGE2 (b) were measured alongside
intracellular phosphorylation of ERK (c).
Significant differences with a p value <0.05
are denoted by “a” for comparisons to
respective static control and “b” for
comparisons to the respective NM control,
and “c” for comparisons to respective SASP
control (mean ± standard deviation, n = 4). IL‐
6, interleukin‐6; NO, nitric oxide; OFF,
oscillatory fluid flow; PGE2, prostaglandin E2;
SASP, senescence‐associated secretory
phenotype

F I G U R E 5 Osteocytes' functional response to ATP is inhibited by the SASP of senescent osteocytes through IL‐6. (a) Extracellular ATP was
measured in response to OFF in MLO‐Y4 cells following 2 days of culture with conditioned media from senescent osteocytes (SASP) or
nonsenescent osteocytes (NM) (mean ± standard deviation, n = 3). (b) Phosphorylation of ERK was measured via western blot and quantified for
MLO‐Y4 cells treated with ATP (100 μM for 15 min). Before treatment, MLO‐Y4 cells were cultured with or without SASP as well as the
neutralizing antibody for IL‐6 (aIL‐6). (c) Western blot and quantified expression of P2X7 receptor relative to Tbp in MLO‐Y4 cells treated with
or without SASP as well as aIL‐6. (d) The mRNA expression of P2rx7 was measured relative to Tbp and normalized to NM controls. Significant
differences with a p value <0.05 are denoted by “a” for comparisons to respective vehicle‐treated control and “b” for comparisons to the
respective ATP‐treated NM control and “c” for comparisons to respective SASP control (mean ± standard deviation, n = 4). ATP, adenosine 5′‐
triphosphate; IL‐6, interleukin‐6; mRNA, messenger RNA; NO, nitric oxide; OFF, oscillatory fluid flow; SASP, senescence‐associated secretory
phenotype
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Both models of senescent cells showed an increase in p16ink4a
alongside decreased proliferation, increased cell size, and increased
β‐galactosidase activity. The increase in p16

ink4a

7

IL‐6 as part of the SASP and the inhibitor effect on osteocyte
mechanotransduction.

in particular is con-

The release of PGE in response to fluid flow is mediated by

sistent with the age‐related changes observed in mice (Farr et al.,

purinergic signaling (Genetos et al., 2007; Li et al., 2005), and is an

2017). However, the decrease in p53 expression among irradiated

essential component to the induction of bone formation (Galea et al.,

MC3T3 cells was unexpected given the prominent function of p53 in

2011; Jee & Ma, 1997). Given that ATP release was still evident

regulating cell cycle arrest. The lack of p53 expression suggests that

despite exposure to the SASP, the lack of PGE2 signaling was then

p16ink4a signaling through retinoblastoma may play a larger role in cell

attributed to a lack of response to ATP, namely, through the P2X7

cycle arrest through the classical p53 pathway (Kumari & Jat, 2021).

receptor. Decreased P2X7 expression was only observed at the

At the same time, the senescent phenotype of irradiated MLO‐Y4

protein level, suggesting a direct or indirect interaction between the

ink4a

cells did not include elevated p53 expression, but increased p16

IL‐6 receptor and P2X7. Considering that activation of the IL‐6 re-

and p21. In contrast, oxidative stress is reported to produce a se-

ceptor induces endocytosis through caveolin phosphorylation

nescent phenotype marked by elevated p21 and p53 without chan-

(Cendrowski et al., 2016) and that phosphorylation of caveolin also

ges in p16

ink4a

(Wei et al., 2021), suggesting that the onset of

senescence in these cells is dependent on the type of trigger.

causes endocytosis of P2X7 (Barth et al., 2007; Gangadharan et al.,
2015), it is possible that exposure to IL‐6 facilitates the endocytosis

Similar to other studies, the SASP profile of the senescent MLO‐

and degradation of P2X7 independent of changes in gene expression.

Y4 cells was in part regulated by NF‐κB. In particular, NF‐κB con-

Overall, the underlying mechanisms by which IL‐6 as part of the SASP

tributed to the expression of IL‐6, IL‐1α, and Cxcl15, but not TNF‐α.

causes a loss in P2X7 receptor remains unclear, but warrants further

In contrast, inhibition of NF‐κB increased p53 and p21 expression,

examination in attempts to understand how to maintain osteocytes'

suggesting that cell‐cycle arrest in the senescent MLO‐Y4 cells is

sensitivity to purinergic signaling.

maintained independent of NF‐κB. Although cross‐talk between NF‐

Our findings also suggest that the SASP of senescent osteocytes

κB and p53 can contribute to the senescent phenotype, they are not

has a larger impact on bone metabolism than senescent osteoblasts.

necessarily mutually inclusive. In fact, RNAi studies have found p53

This is consistent with previous work in which eliminating senescent

and p16ink4a expression to remain unaffected when suppressing NF‐

cells, including senescent osteocytes, effectively prevents bone loss

κΒ in senescent cells despite significant reductions in the in-

(Farr et al., 2017), while other models that do not eliminate senescent

flammatory profile (Chien et al., 2011; Salminen et al., 2012). In ad-

osteocytes exhibit no changes in bone loss (Kim et al., 2019). Al-

dition, studies have also found p53 and NF‐κB to counteract

though the exact mechanisms by which bone formation was restored

each other and that their increased activity with senescence is

is still unclear, our findings suggest potential gains in mechan-

regulated independent of each other (Ak & Levine, 2010; Salminen &

otransduction may be a contributing factor. In particular, osteocytes'

Kaarniranta, 2011). Overall, NF‐κB appears to play a larger role

gains in Wnt10b expression under loading would increase osteoblast

in regulating the SASP and based on our findings may provide a

recruitment and activation (Bennett et al., 2005; Stevens et al., 2010).

novel target toward reducing the paracrine function of senescent

Gains in PGE2 signaling are also expected to restore osteocytes ca-

cells.

pacity to downregulate Sost under loading (Galea et al., 2011). Un-

The SASP profile of senescent osteocytes includes numerous

fortunately, the use of MLO‐Y4 cells did not allow us to measure

cytokines and chemokines. Of those examined in this study, we

changes in Sost expression. Despite this limitation, our findings add to

found the relative increase in IL‐6 expression to be greater than that

the emerging role of senescent osteocytes and their negative effect

of IL‐1α, TNF‐α, or Cxcl15. Based on our findings, IL‐6 played a

on bone mass and mechanotransduction. Another limitation in this

significant role in inhibiting the mechanotransduction of osteocytes.

study was the lack of other senescent cell types, such as fibroblasts

Neutralizing IL‐6 when treating osteocytes with the SASP restored

or adipocytes, which also express high levels of IL‐6 as part of their

ERK phosphorylation alongside the release of PGE2. Of note, we

SASP alongside several others specific to their phenotype (Farr et al.,

found the release of PGE2 exceeded that of controls when neu-

2016). Given the paracrine function of the SASP, other tissues or cell

tralizing IL‐6, suggesting that the other SASP components may enable

types may also effect osteocytes' mechanotransduction and would be

osteocytes to compensate against the effects of IL‐6. Independent of

worth exploring further in future studies.

the SASP, directly treating osteocytes with IL‐6 has little effect on

In conclusion, our study demonstrates that the mechan-

the release of NO, while treating with IL‐1α or TNF‐α can completely

otransduction of otherwise healthy osteocytes is inhibited by the

abolish NO release alongside the release of PGE2 (Bakker et al.,

SASP of neighboring senescent osteocytes. Furthermore, IL‐6 ap-

2009, 2014) As a result, it was surprising that neutralizing the SASP

pears to be a key component of the SASP contributing to the loss in

component IL‐1α did not restore osteocytes' release of NO or PGE2.

mechanotransduction by decreasing osteocytes' sensitivity to pur-

The discrepancy between these studies may extend from differences

inergic signaling. Altogether, our findings suggest that the accumu-

in concentrations. Unfortunately, the concentration of IL‐1α was not

lation of senescent osteocytes may contribute to age‐related bone

quantified in our study and presented a limitation to understanding

loss through the loss of mechanotransduction and that targeting

the relative production of each SASP component at the protein level.

SASP component IL‐6 has the potential to enhance the anabolic re-

However, these findings demonstrate the unique function of

sponse to loading.
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